Oral Presentation No. 107 Achieving higher efficacy without compromising safety with Factor XI inhibitors versus low-molecular-weight heparin for the prevention of venous thromboembolism in major orthopedic surgery – Systematic Review and Meta-Analysis - KIVIRID

Oral Presentation No. 107 Achieving higher efficacy without compromising safety with Factor XI inhibitors versus low-molecular-weight heparin for the prevention of venous thromboembolism in major orthopedic surgery – Systematic Review and Meta-Analysis

Authors: João Presume, Jorge Ferreira, Regina Ribeiras, Miguel Mendes

Published: 2022-10-21

DOI: 10.1093/cvr/cvac157.087

Source: Full article

Abstract

Abstract